Adverum Biotechnologies, Inc. (ADVM)

Adverum Biotechnologies Statistics

Total Valuation

ADVM has a market cap or net worth of $156.84 million. The enterprise value is $56.90 million.

Market Cap	156.84M
Enterprise Value	56.90M

Important Dates

The last earnings date was Monday, November 4, 2024, after market close.

Earnings Date	Nov 4, 2024
Ex-Dividend Date	n/a

Share Statistics

ADVM has 20.80 million shares outstanding. The number of shares has increased by 43.94% in one year.

Shares Outstanding	20.80M
Shares Change (YoY)	+43.94%
Shares Change (QoQ)	+26.54%
Owned by Insiders (%)	6.73%
Owned by Institutions (%)	57.83%
Float	12.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	128.83
Forward PS	n/a
PB Ratio	1.09
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	56.90
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.82, with a Debt / Equity ratio of 0.51.

Current Ratio	5.82
Quick Ratio	5.54
Debt / Equity	0.51
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -76.26% and return on invested capital (ROIC) is -32.50%.

Return on Equity (ROE)	-76.26%
Return on Assets (ROA)	-29.83%
Return on Capital (ROIC)	-32.50%
Revenue Per Employee	$8,264
Profits Per Employee	-$777,777
Employee Count	121
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	-1.13M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.03% in the last 52 weeks. The beta is 1.01, so ADVM's price volatility has been similar to the market average.

Beta (5Y)	1.01
52-Week Price Change	-19.03%
50-Day Moving Average	7.36
200-Day Moving Average	10.30
Relative Strength Index (RSI)	47.80
Average Volume (20 Days)	164,477

Short Selling Information

The latest short interest is 1.70 million, so 8.16% of the outstanding shares have been sold short.

Short Interest	1.70M
Short Previous Month	1.48M
Short % of Shares Out	8.16%
Short % of Float	13.49%
Short Ratio (days to cover)	7.21

Income Statement

In the last 12 months, ADVM had revenue of $1.00 million and -$94.11 million in losses. Loss per share was -$5.51.

Revenue	1.00M
Gross Profit	-76.68M
Operating Income	-102.88M
Pretax Income	-113.99M
Net Income	-94.11M
EBITDA	-99.02M
EBIT	-102.88M
Loss Per Share	-$5.51

Balance Sheet

The company has $153.24 million in cash and $73.26 million in debt, giving a net cash position of $79.98 million or $3.84 per share.

Cash & Cash Equivalents	153.24M
Total Debt	73.26M
Net Cash	79.98M
Net Cash Per Share	$3.84
Equity (Book Value)	144.12M
Book Value Per Share	6.93
Working Capital	133.42M

Cash Flow

In the last 12 months, operating cash flow was -$85.54 million and capital expenditures -$519,000, giving a free cash flow of -$89.12 million.

Operating Cash Flow	-85.54M
Capital Expenditures	-519,000
Free Cash Flow	-89.12M
FCF Per Share	-$4.28

Margins

Gross Margin	n/a
Operating Margin	-10,287.60%
Pretax Margin	-9,524.40%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ADVM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-43.94%
Shareholder Yield	-43.94%
Earnings Yield	-60.00%
FCF Yield	-56.82%

Analyst Forecast

The average price target for ADVM is $28.17, which is 273.61% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$28.17
Price Target Difference	273.61%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	60.64%
EPS Growth Forecast (5Y)	-19.76%

Stock Splits

The last stock split was on March 21, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Mar 21, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2